TICKERNOMICS Sign up
Last Update: 2024-12-27 15:24:50
Ceribell Inc. ( CBLL ) https://ceribell.com
26.48USD
Sector:
Healthcare
Industry:
Medical Devices
Country:
United States
1y
3y
5y
10y
Historical Returns*:
SPY
27.80%
CBLL
0.00%
SPY
32.66%
CBLL
0.00%
SPY
108.59%
CBLL
0.00%
SPY
302.52%
CBLL
0.00%
*Assumes dividends reinvested
Market Stats:
Market Capitalization($MM)
Enterprise Value($MM)
Daily Volume(MM)
915.78
921.17
0.12
Valuation Metrics:
Price/Earnings Ratio
Price/Sales Ratio
Price/Book Value
FCF Yield(%)
Dividend Yield(%)
EV/EBITDA
-25.33
15.25
80.12
0.00
0.00
-25.66
Profitability Stats:
Operating Margin %(ttm)
Gross Profit %(ttm)
EBITDA Margin %(ttm)
-57.79
87.30
-56.00
Shareholder Value Creation:
Cost of Capital %(est)
ROIC %(ttm)
ROCE %(ttm)
Beta
4.32
-56.44
-64.54
0.00
Other Earnings and Cash Flow Stats:
Ceribell Inc. ( CBLL ) Net Income TTM ($MM) is -36.15
Ceribell Inc. ( CBLL ) Operating Income TTM ($MM) is -35.21
Ceribell Inc. ( CBLL ) Owners' Earnings Annual ($MM) is 0.00
Ceribell Inc. ( CBLL ) Current Price to Owners' Earnings ratio is 0.00
Ceribell Inc. ( CBLL ) EBITDA TTM ($MM) is -34.28
Ceribell Inc. ( CBLL ) EBITDA Margin is -56.00%
Capital Allocation:
Ceribell Inc. ( CBLL ) has paid 0.00 dividends per share and bought back -10.694414 million shares in the past 12 months
Ceribell Inc. ( CBLL ) has increased its debt by 0.648 million USD in the last 12 months
Capital Structure:
Ceribell Inc. ( CBLL ) Interest-bearing Debt ($MM) as of last quarter is 19
Ceribell Inc. ( CBLL ) Annual Working Capital Investments ($MM) are -4
Ceribell Inc. ( CBLL ) Book Value ($MM) as of last quarter is 11
Ceribell Inc. ( CBLL ) Debt/Capital as of last quarter is -15%
Other Balance Sheet Stats:
Ceribell Inc. ( CBLL ) has 14 million in cash on hand as of last quarter
Ceribell Inc. ( CBLL ) has 13 million of liabilities due within 12 months, and long term debt 31 as of last quarter
Ceribell Inc. ( CBLL ) has 34 common shares outstanding as of last quarter
Ceribell Inc. ( CBLL ) has 0 million USD of preferred stock value
Academic Scores:
Ceribell Inc. ( CBLL ) Altman Z-Score is 10.17 as of last quarter
Ceribell Inc. ( CBLL ) Piotroski Score is 3.00 as of last quarter
Corporate Governance:
Ceribell Inc. ( CBLL ) largest shareholder is owning shares at 0.00 ($MM) value
(an insider) shares of Ceribell Inc. ( CBLL ) for the amount of $ on
0.00% of Ceribell Inc. ( CBLL ) is held by insiders, and 0.00% is held by institutions
Ceribell Inc. ( CBLL ) went public on 2024-10-11
Other Ceribell Inc. ( CBLL ) financial metrics:
FCF:-34.07
Unlevered Free Cash Flow:0.00
EPS:-1.22
Operating Margin:-57.79
Gross Profit Margin:87.30
Div. Payout Ratio%:0.00
Div. Growth YoY%:0.00
Equity Return%:30.64
Beta:0.00
Buffet's Owners Earnings:0.00
Price to Owner's Earnings:0.00
About Ceribell Inc. ( CBLL ) :
CeriBell, Inc. develops AI based point-of-care electroencephalography (EEG) technology for the detection and treatment of neurological conditions. The company develops Ceribell System, a novel, point-of-care EEG platform to address the unmet needs of patients in the acute care setting. It also offers EEG disposable headbands; and pocket-sized battery-operated recorders. The company was formerly known as Brain Stethoscope, Inc. and changed its name to CeriBell, Inc. in August 2015. The company was incorporated in 2014 and is based in Sunnyvale, California.
User Content from Tickernomics. Created by Luminus.
DISCLAIMER

This web site and its creators are not certified financial advisors. All opinions/suggestions expressed on this website should not be treated as specific inducement to make a particular investment or follow a particular strategy, but only as an expression of an opinion.The Company doesn't warrant the information provided on the website for its completeness or accuracy, and it should not be relied upon as such. The Company is not under any obligation to update or correct any information provided on this website.The content of this website is published in the United States of America and persons who access it agree to do so in accordance with applicable U.S. law.Past performance is not indicative of future results. The Company doesn't guarantee any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment discussed on this website.Strategies or investments discussed may fluctuate in price or value. Investors may get back less than invested. Investments or strategies mentioned on this website may not be suitable for you. This material does not take into account your particular investment objectives,financial situation or needs and is not intended as recommendations appropriate for you. You must make an independent decision regarding investments or strategies mentioned on this website. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.